Drugs / [123I] 5-IA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00397696 | Nov 2006 → Dec 2011 | Parkinson disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [123I] 5-IA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00397696 ↗ |